Isis Pharmaceuticals Contemplating Name Change Post France Attacks

Business, International News, News

Isis Pharma

Juliet said “What’s in a name? A rose by any other name would smell as sweet.” in the William Shakespeare classic Romeo and Juliet. The reality, however, seems to be a bit more harsher. At least for California based biotech company Isis Pharmaceuticals. They are quite well known for their cancer, neurological disorder and heart disease related drugs. The company was named after the Egyptian goddess “Isis”, a word that means good health. But their namesake terrorist group in the middle east which has rose to prominence in the last couple of years has the company scurrying for a new identity.

Until last year the company had denied any claims that a name change was being considered. The recent Paris attacks, however, have tilted the playing field considerably. Monday saw the Isis stock plummet 4% despite the market being bullish. Company’s vice president for corporate communications and investor relations D. Wade Walke said, “Even though people know we’re not associated with the terrorist group, the name itself has so many negative connotations, it’s obviously not getting better over time.”.

While Walke associated the price drop with Clovis Oncology, a rival whose shares nose dived 70%, the fact that a name change might be in order is quite evident at this point. Just like Isis Mobile Wallet changed its name to Softcard last year after the Islamic State terrorist group rose to prominence.

Image Courtesy:

Source: ABP News

Please follow and like us:
Soumyajit DasMazumdar on FacebookSoumyajit DasMazumdar on LinkedinSoumyajit DasMazumdar on Twitter
Soumyajit DasMazumdar
Soumyajit is an SAP technical consultant with a flair for writing. An avid blog reader, he started off with a free WordPress blog and slowly moved to his own personal news and blog site. Apart from writing he loves reading books, playing table tennis and long bike trips. He is currently trying to learn playing guitar and failing miserably.


Leave a Reply